nodes	percent_of_prediction	percent_of_DWPC	metapath
Budesonide—NR3C1—hematologic cancer	0.0831	1	CbGaD
Budesonide—Corticosteroid Hormone Receptor Agonists—Betamethasone—hematologic cancer	0.0676	0.209	CiPCiCtD
Budesonide—Corticosteroid Hormone Receptor Agonists—Dexamethasone—hematologic cancer	0.0676	0.209	CiPCiCtD
Budesonide—Corticosteroid Hormone Receptor Agonists—Triamcinolone—hematologic cancer	0.0653	0.202	CiPCiCtD
Budesonide—Corticosteroid Hormone Receptor Agonists—Prednisolone—hematologic cancer	0.0633	0.195	CiPCiCtD
Budesonide—Corticosteroid Hormone Receptor Agonists—Prednisone—hematologic cancer	0.0597	0.185	CiPCiCtD
Budesonide—Betamethasone—hematologic cancer	0.0488	0.208	CrCtD
Budesonide—Dexamethasone—hematologic cancer	0.0488	0.208	CrCtD
Budesonide—Triamcinolone—hematologic cancer	0.0476	0.203	CrCtD
Budesonide—Prednisone—hematologic cancer	0.0452	0.193	CrCtD
Budesonide—Prednisolone—hematologic cancer	0.0441	0.188	CrCtD
Budesonide—NR3C1—Triamcinolone—hematologic cancer	0.0135	0.117	CbGbCtD
Budesonide—NR3C1—Betamethasone—hematologic cancer	0.0116	0.1	CbGbCtD
Budesonide—NR3C1—Prednisolone—hematologic cancer	0.0114	0.099	CbGbCtD
Budesonide—NR3C1—Prednisone—hematologic cancer	0.0108	0.0935	CbGbCtD
Budesonide—NR3C1—Dexamethasone—hematologic cancer	0.00673	0.0584	CbGbCtD
Budesonide—CYP3A4—Bexarotene—hematologic cancer	0.00508	0.0441	CbGbCtD
Budesonide—CYP3A4—Lomustine—hematologic cancer	0.00473	0.041	CbGbCtD
Budesonide—CYP3A4—Busulfan—hematologic cancer	0.00473	0.041	CbGbCtD
Budesonide—CYP3A4—Thiotepa—hematologic cancer	0.00421	0.0365	CbGbCtD
Budesonide—CYP3A4—Methoxsalen—hematologic cancer	0.00328	0.0284	CbGbCtD
Budesonide—CYP3A4—Bortezomib—hematologic cancer	0.00312	0.027	CbGbCtD
Budesonide—CYP3A4—Daunorubicin—hematologic cancer	0.00298	0.0259	CbGbCtD
Budesonide—CYP3A4—Cytarabine—hematologic cancer	0.00263	0.0228	CbGbCtD
Budesonide—CYP3A4—Teniposide—hematologic cancer	0.00259	0.0225	CbGbCtD
Budesonide—CYP3A4—Ifosfamide—hematologic cancer	0.00239	0.0207	CbGbCtD
Budesonide—CYP3A4—Imatinib—hematologic cancer	0.00228	0.0198	CbGbCtD
Budesonide—CYP3A4—Ruxolitinib—hematologic cancer	0.00215	0.0186	CbGbCtD
Budesonide—CYP3A4—Nilotinib—hematologic cancer	0.00207	0.018	CbGbCtD
Budesonide—CYP3A4—Vinorelbine—hematologic cancer	0.00206	0.0178	CbGbCtD
Budesonide—CYP3A4—Triamcinolone—hematologic cancer	0.00188	0.0163	CbGbCtD
Budesonide—CYP3A4—Dasatinib—hematologic cancer	0.00183	0.0159	CbGbCtD
Budesonide—CYP3A4—Mitoxantrone—hematologic cancer	0.00181	0.0157	CbGbCtD
Budesonide—Ciclesonide—Prednisone—hematologic cancer	0.00176	0.0104	CrCrCtD
Budesonide—Ciclesonide—Prednisolone—hematologic cancer	0.00171	0.0101	CrCrCtD
Budesonide—Flurandrenolide—Dexamethasone—hematologic cancer	0.00169	0.01	CrCrCtD
Budesonide—Flurandrenolide—Betamethasone—hematologic cancer	0.00169	0.01	CrCrCtD
Budesonide—CYP3A4—Betamethasone—hematologic cancer	0.00161	0.014	CbGbCtD
Budesonide—CYP3A4—Prednisolone—hematologic cancer	0.00159	0.0138	CbGbCtD
Budesonide—Flurandrenolide—Prednisolone—hematologic cancer	0.00153	0.00905	CrCrCtD
Budesonide—CYP3A4—Prednisone—hematologic cancer	0.0015	0.013	CbGbCtD
Budesonide—Prednicarbate—Dexamethasone—hematologic cancer	0.00149	0.00879	CrCrCtD
Budesonide—Prednicarbate—Betamethasone—hematologic cancer	0.00149	0.00879	CrCrCtD
Budesonide—Fluocinonide—Betamethasone—hematologic cancer	0.00149	0.00879	CrCrCtD
Budesonide—Fluocinonide—Dexamethasone—hematologic cancer	0.00149	0.00879	CrCrCtD
Budesonide—Beclomethasone—Betamethasone—hematologic cancer	0.00149	0.00879	CrCrCtD
Budesonide—Clocortolone—Dexamethasone—hematologic cancer	0.00149	0.00879	CrCrCtD
Budesonide—Testolactone—Betamethasone—hematologic cancer	0.00149	0.00879	CrCrCtD
Budesonide—Testolactone—Dexamethasone—hematologic cancer	0.00149	0.00879	CrCrCtD
Budesonide—Beclomethasone—Dexamethasone—hematologic cancer	0.00149	0.00879	CrCrCtD
Budesonide—Clocortolone—Betamethasone—hematologic cancer	0.00149	0.00879	CrCrCtD
Budesonide—Hydrocortamate—Prednisone—hematologic cancer	0.00147	0.00867	CrCrCtD
Budesonide—Prednicarbate—Triamcinolone—hematologic cancer	0.00146	0.00859	CrCrCtD
Budesonide—Beclomethasone—Triamcinolone—hematologic cancer	0.00146	0.00859	CrCrCtD
Budesonide—Testolactone—Triamcinolone—hematologic cancer	0.00146	0.00859	CrCrCtD
Budesonide—Clocortolone—Triamcinolone—hematologic cancer	0.00146	0.00859	CrCrCtD
Budesonide—Fluocinonide—Triamcinolone—hematologic cancer	0.00146	0.00859	CrCrCtD
Budesonide—Fluocortolone—Betamethasone—hematologic cancer	0.00145	0.00854	CrCrCtD
Budesonide—Fluocortolone—Dexamethasone—hematologic cancer	0.00145	0.00854	CrCrCtD
Budesonide—Hydrocortamate—Prednisolone—hematologic cancer	0.00143	0.00846	CrCrCtD
Budesonide—CYP3A4—Irinotecan—hematologic cancer	0.00143	0.0124	CbGbCtD
Budesonide—Fluocortolone—Triamcinolone—hematologic cancer	0.00141	0.00834	CrCrCtD
Budesonide—Alclometasone—Dexamethasone—hematologic cancer	0.00141	0.0083	CrCrCtD
Budesonide—Fluocinolone Acetonide—Dexamethasone—hematologic cancer	0.00141	0.0083	CrCrCtD
Budesonide—Fluocinolone Acetonide—Betamethasone—hematologic cancer	0.00141	0.0083	CrCrCtD
Budesonide—Alclometasone—Betamethasone—hematologic cancer	0.00141	0.0083	CrCrCtD
Budesonide—Prednicarbate—Prednisone—hematologic cancer	0.00138	0.00815	CrCrCtD
Budesonide—Testolactone—Prednisone—hematologic cancer	0.00138	0.00815	CrCrCtD
Budesonide—Alclometasone—Triamcinolone—hematologic cancer	0.00137	0.00811	CrCrCtD
Budesonide—Fluocinolone Acetonide—Triamcinolone—hematologic cancer	0.00137	0.00811	CrCrCtD
Budesonide—Amcinonide—Betamethasone—hematologic cancer	0.00137	0.00808	CrCrCtD
Budesonide—Amcinonide—Dexamethasone—hematologic cancer	0.00137	0.00808	CrCrCtD
Budesonide—Beclomethasone—Prednisolone—hematologic cancer	0.00135	0.00796	CrCrCtD
Budesonide—Clocortolone—Prednisolone—hematologic cancer	0.00135	0.00796	CrCrCtD
Budesonide—Testolactone—Prednisolone—hematologic cancer	0.00135	0.00796	CrCrCtD
Budesonide—Prednicarbate—Prednisolone—hematologic cancer	0.00135	0.00796	CrCrCtD
Budesonide—Fluocortolone—Prednisone—hematologic cancer	0.00134	0.00792	CrCrCtD
Budesonide—Amcinonide—Triamcinolone—hematologic cancer	0.00134	0.0079	CrCrCtD
Budesonide—Flunisolide—Betamethasone—hematologic cancer	0.00133	0.00787	CrCrCtD
Budesonide—Diflorasone—Dexamethasone—hematologic cancer	0.00133	0.00787	CrCrCtD
Budesonide—Clobetasol propionate—Dexamethasone—hematologic cancer	0.00133	0.00787	CrCrCtD
Budesonide—Clobetasol propionate—Betamethasone—hematologic cancer	0.00133	0.00787	CrCrCtD
Budesonide—Desonide—Dexamethasone—hematologic cancer	0.00133	0.00787	CrCrCtD
Budesonide—Diflorasone—Betamethasone—hematologic cancer	0.00133	0.00787	CrCrCtD
Budesonide—Flunisolide—Dexamethasone—hematologic cancer	0.00133	0.00787	CrCrCtD
Budesonide—Prednisone—Betamethasone—hematologic cancer	0.00133	0.00787	CrCrCtD
Budesonide—Prednisone—Dexamethasone—hematologic cancer	0.00133	0.00787	CrCrCtD
Budesonide—Desonide—Betamethasone—hematologic cancer	0.00133	0.00787	CrCrCtD
Budesonide—Fluocortolone—Prednisolone—hematologic cancer	0.00131	0.00773	CrCrCtD
Budesonide—Alclometasone—Prednisone—hematologic cancer	0.0013	0.0077	CrCrCtD
Budesonide—Prednisone—Triamcinolone—hematologic cancer	0.0013	0.00769	CrCrCtD
Budesonide—Flunisolide—Triamcinolone—hematologic cancer	0.0013	0.00769	CrCrCtD
Budesonide—Desonide—Triamcinolone—hematologic cancer	0.0013	0.00769	CrCrCtD
Budesonide—Diflorasone—Triamcinolone—hematologic cancer	0.0013	0.00769	CrCrCtD
Budesonide—Clobetasol propionate—Triamcinolone—hematologic cancer	0.0013	0.00769	CrCrCtD
Budesonide—Paramethasone—Dexamethasone—hematologic cancer	0.0013	0.00768	CrCrCtD
Budesonide—Paramethasone—Betamethasone—hematologic cancer	0.0013	0.00768	CrCrCtD
Budesonide—Alclometasone—Prednisolone—hematologic cancer	0.00127	0.00752	CrCrCtD
Budesonide—Fluocinolone Acetonide—Prednisolone—hematologic cancer	0.00127	0.00752	CrCrCtD
Budesonide—Paramethasone—Triamcinolone—hematologic cancer	0.00127	0.0075	CrCrCtD
Budesonide—Amcinonide—Prednisone—hematologic cancer	0.00127	0.00749	CrCrCtD
Budesonide—Desoximetasone—Dexamethasone—hematologic cancer	0.00127	0.00749	CrCrCtD
Budesonide—Desoximetasone—Betamethasone—hematologic cancer	0.00127	0.00749	CrCrCtD
Budesonide—CYP3A4—Vinblastine—hematologic cancer	0.00127	0.011	CbGbCtD
Budesonide—CYP3A4—Vincristine—hematologic cancer	0.00125	0.0108	CbGbCtD
Budesonide—Desoximetasone—Triamcinolone—hematologic cancer	0.00124	0.00732	CrCrCtD
Budesonide—Amcinonide—Prednisolone—hematologic cancer	0.00124	0.00732	CrCrCtD
Budesonide—Fluorometholone—Dexamethasone—hematologic cancer	0.00124	0.00731	CrCrCtD
Budesonide—Mometasone—Dexamethasone—hematologic cancer	0.00124	0.00731	CrCrCtD
Budesonide—Mometasone—Betamethasone—hematologic cancer	0.00124	0.00731	CrCrCtD
Budesonide—Triamcinolone—Dexamethasone—hematologic cancer	0.00124	0.00731	CrCrCtD
Budesonide—Fluprednidene Acetate—Betamethasone—hematologic cancer	0.00124	0.00731	CrCrCtD
Budesonide—Fluprednidene Acetate—Dexamethasone—hematologic cancer	0.00124	0.00731	CrCrCtD
Budesonide—Loteprednol—Dexamethasone—hematologic cancer	0.00124	0.00731	CrCrCtD
Budesonide—Loteprednol—Betamethasone—hematologic cancer	0.00124	0.00731	CrCrCtD
Budesonide—Triamcinolone—Betamethasone—hematologic cancer	0.00124	0.00731	CrCrCtD
Budesonide—Fluorometholone—Betamethasone—hematologic cancer	0.00124	0.00731	CrCrCtD
Budesonide—Diflorasone—Prednisone—hematologic cancer	0.00124	0.0073	CrCrCtD
Budesonide—Flunisolide—Prednisone—hematologic cancer	0.00124	0.0073	CrCrCtD
Budesonide—Desonide—Prednisone—hematologic cancer	0.00124	0.0073	CrCrCtD
Budesonide—Clobetasol propionate—Prednisone—hematologic cancer	0.00124	0.0073	CrCrCtD
Budesonide—Rimexolone—Betamethasone—hematologic cancer	0.00121	0.00714	CrCrCtD
Budesonide—Dexamethasone—Betamethasone—hematologic cancer	0.00121	0.00714	CrCrCtD
Budesonide—Rimexolone—Dexamethasone—hematologic cancer	0.00121	0.00714	CrCrCtD
Budesonide—Betamethasone—Dexamethasone—hematologic cancer	0.00121	0.00714	CrCrCtD
Budesonide—Fluprednidene Acetate—Triamcinolone—hematologic cancer	0.00121	0.00714	CrCrCtD
Budesonide—Fluorometholone—Triamcinolone—hematologic cancer	0.00121	0.00714	CrCrCtD
Budesonide—Mometasone—Triamcinolone—hematologic cancer	0.00121	0.00714	CrCrCtD
Budesonide—Loteprednol—Triamcinolone—hematologic cancer	0.00121	0.00714	CrCrCtD
Budesonide—Prednisone—Prednisolone—hematologic cancer	0.00121	0.00713	CrCrCtD
Budesonide—Diflorasone—Prednisolone—hematologic cancer	0.00121	0.00713	CrCrCtD
Budesonide—Flunisolide—Prednisolone—hematologic cancer	0.00121	0.00713	CrCrCtD
Budesonide—Desonide—Prednisolone—hematologic cancer	0.00121	0.00713	CrCrCtD
Budesonide—Clobetasol propionate—Prednisolone—hematologic cancer	0.00121	0.00713	CrCrCtD
Budesonide—Paramethasone—Prednisone—hematologic cancer	0.00121	0.00712	CrCrCtD
Budesonide—Betamethasone—Triamcinolone—hematologic cancer	0.00118	0.00698	CrCrCtD
Budesonide—Dexamethasone—Triamcinolone—hematologic cancer	0.00118	0.00698	CrCrCtD
Budesonide—Rimexolone—Triamcinolone—hematologic cancer	0.00118	0.00698	CrCrCtD
Budesonide—Paramethasone—Prednisolone—hematologic cancer	0.00118	0.00695	CrCrCtD
Budesonide—Desoximetasone—Prednisone—hematologic cancer	0.00118	0.00694	CrCrCtD
Budesonide—Methylprednisolone—Betamethasone—hematologic cancer	0.00116	0.00683	CrCrCtD
Budesonide—Methylprednisolone—Dexamethasone—hematologic cancer	0.00116	0.00683	CrCrCtD
Budesonide—Fluorometholone—Prednisone—hematologic cancer	0.00115	0.00678	CrCrCtD
Budesonide—Triamcinolone—Prednisone—hematologic cancer	0.00115	0.00678	CrCrCtD
Budesonide—Mometasone—Prednisone—hematologic cancer	0.00115	0.00678	CrCrCtD
Budesonide—Fluprednidene Acetate—Prednisone—hematologic cancer	0.00115	0.00678	CrCrCtD
Budesonide—Loteprednol—Prednisone—hematologic cancer	0.00115	0.00678	CrCrCtD
Budesonide—Desoximetasone—Prednisolone—hematologic cancer	0.00115	0.00678	CrCrCtD
Budesonide—CYP3A4—Etoposide—hematologic cancer	0.00114	0.00991	CbGbCtD
Budesonide—Prednisolone—Dexamethasone—hematologic cancer	0.00113	0.00669	CrCrCtD
Budesonide—Prednisolone—Betamethasone—hematologic cancer	0.00113	0.00669	CrCrCtD
Budesonide—Methylprednisolone—Triamcinolone—hematologic cancer	0.00113	0.00668	CrCrCtD
Budesonide—Betamethasone—Prednisone—hematologic cancer	0.00112	0.00662	CrCrCtD
Budesonide—Rimexolone—Prednisone—hematologic cancer	0.00112	0.00662	CrCrCtD
Budesonide—Dexamethasone—Prednisone—hematologic cancer	0.00112	0.00662	CrCrCtD
Budesonide—Mometasone—Prednisolone—hematologic cancer	0.00112	0.00662	CrCrCtD
Budesonide—Fluprednidene Acetate—Prednisolone—hematologic cancer	0.00112	0.00662	CrCrCtD
Budesonide—Loteprednol—Prednisolone—hematologic cancer	0.00112	0.00662	CrCrCtD
Budesonide—Triamcinolone—Prednisolone—hematologic cancer	0.00112	0.00662	CrCrCtD
Budesonide—Fluorometholone—Prednisolone—hematologic cancer	0.00112	0.00662	CrCrCtD
Budesonide—Prednisolone—Triamcinolone—hematologic cancer	0.00111	0.00654	CrCrCtD
Budesonide—Betamethasone—Prednisolone—hematologic cancer	0.0011	0.00647	CrCrCtD
Budesonide—Rimexolone—Prednisolone—hematologic cancer	0.0011	0.00647	CrCrCtD
Budesonide—Dexamethasone—Prednisolone—hematologic cancer	0.0011	0.00647	CrCrCtD
Budesonide—Hydrocortisone—Dexamethasone—hematologic cancer	0.00109	0.00642	CrCrCtD
Budesonide—Hydrocortisone—Betamethasone—hematologic cancer	0.00109	0.00642	CrCrCtD
Budesonide—Methylprednisolone—Prednisone—hematologic cancer	0.00107	0.00634	CrCrCtD
Budesonide—Hydrocortisone—Triamcinolone—hematologic cancer	0.00106	0.00627	CrCrCtD
Budesonide—Prednisolone—Prednisone—hematologic cancer	0.00105	0.0062	CrCrCtD
Budesonide—Methylprednisolone—Prednisolone—hematologic cancer	0.00105	0.00619	CrCrCtD
Budesonide—Hydrocortisone—Prednisone—hematologic cancer	0.00101	0.00595	CrCrCtD
Budesonide—Hydrocortisone—Prednisolone—hematologic cancer	0.000984	0.00581	CrCrCtD
Budesonide—CYP3A4—Dexamethasone—hematologic cancer	0.000939	0.00815	CbGbCtD
Budesonide—CYP3A4—Doxorubicin—hematologic cancer	0.000779	0.00676	CbGbCtD
Budesonide—Clocortolone—NR3C1—hematologic cancer	5.08e-05	0.0507	CrCbGaD
Budesonide—Prednicarbate—NR3C1—hematologic cancer	5.08e-05	0.0507	CrCbGaD
Budesonide—Diflorasone—NR3C1—hematologic cancer	4.81e-05	0.048	CrCbGaD
Budesonide—Desonide—NR3C1—hematologic cancer	4.81e-05	0.048	CrCbGaD
Budesonide—Desoximetasone—NR3C1—hematologic cancer	4.69e-05	0.0468	CrCbGaD
Budesonide—Loteprednol—NR3C1—hematologic cancer	4.63e-05	0.0462	CrCbGaD
Budesonide—NR3C1—Adipogenesis—NCOR2—hematologic cancer	4.57e-05	0.00331	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—GATA3—hematologic cancer	4.48e-05	0.00325	CbGpPWpGaD
Budesonide—NR3C1—Nuclear Receptors—ESR1—hematologic cancer	4.46e-05	0.00324	CbGpPWpGaD
Budesonide—NR3C1—Signaling events mediated by HDAC Class II—ESR1—hematologic cancer	4.46e-05	0.00324	CbGpPWpGaD
Budesonide—CYP3A4—Estrogen metabolism—NQO1—hematologic cancer	4.46e-05	0.00324	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—GATA3—hematologic cancer	4.43e-05	0.00322	CbGpPWpGaD
Budesonide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC3—hematologic cancer	4.37e-05	0.00317	CbGpPWpGaD
Budesonide—NR3C1—Regulation of Androgen receptor activity—FOXO1—hematologic cancer	4.24e-05	0.00308	CbGpPWpGaD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—hematologic cancer	4.23e-05	0.00307	CbGpPWpGaD
Budesonide—NR3C1—Circadian Clock—NCOR1—hematologic cancer	4.23e-05	0.00307	CbGpPWpGaD
Budesonide—NR3C1—Endoderm Differentiation—STAT1—hematologic cancer	4.22e-05	0.00306	CbGpPWpGaD
Budesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—hematologic cancer	4.16e-05	0.00302	CbGpPWpGaD
Budesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—hematologic cancer	4.16e-05	0.00302	CbGpPWpGaD
Budesonide—CYP3A4—Constitutive Androstane Receptor Pathway—UGT1A1—hematologic cancer	4.11e-05	0.00298	CbGpPWpGaD
Budesonide—Flurandrenolide—NR3C1—hematologic cancer	4.1e-05	0.0409	CrCbGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC2—hematologic cancer	4.09e-05	0.00297	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—HDAC2—hematologic cancer	4.05e-05	0.00294	CbGpPWpGaD
Budesonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—hematologic cancer	4e-05	0.0029	CbGpPWpGaD
Budesonide—Hydrocortamate—NR3C1—hematologic cancer	3.97e-05	0.0396	CrCbGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—HSP90AA1—hematologic cancer	3.77e-05	0.00273	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—RUNX3—hematologic cancer	3.72e-05	0.0027	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—STAT5B—hematologic cancer	3.71e-05	0.00269	CbGpPWpGaD
Budesonide—Amcinonide—NR3C1—hematologic cancer	3.69e-05	0.0368	CrCbGaD
Budesonide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—hematologic cancer	3.69e-05	0.00268	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—STAT1—hematologic cancer	3.63e-05	0.00264	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—HDAC9—hematologic cancer	3.6e-05	0.00261	CbGpPWpGaD
Budesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—CREB1—hematologic cancer	3.57e-05	0.00259	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—FOXM1—hematologic cancer	3.56e-05	0.00259	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—hematologic cancer	3.55e-05	0.00258	CbGpPWpGaD
Budesonide—NR3C1—Nuclear Receptor transcription pathway—ESR1—hematologic cancer	3.53e-05	0.00256	CbGpPWpGaD
Budesonide—Mometasone—NR3C1—hematologic cancer	3.51e-05	0.035	CrCbGaD
Budesonide—NR3C1—Regulation of Androgen receptor activity—MAPK14—hematologic cancer	3.49e-05	0.00253	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—IL10—hematologic cancer	3.49e-05	0.00253	CbGpPWpGaD
Budesonide—Rimexolone—NR3C1—hematologic cancer	3.47e-05	0.0346	CrCbGaD
Budesonide—NR3C1—AP-1 transcription factor network—CSF2—hematologic cancer	3.45e-05	0.0025	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—MYB—hematologic cancer	3.43e-05	0.00249	CbGpPWpGaD
Budesonide—CYP3A4—Estrogen metabolism—GSTM1—hematologic cancer	3.42e-05	0.00248	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—IL4—hematologic cancer	3.39e-05	0.00246	CbGpPWpGaD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—hematologic cancer	3.35e-05	0.00243	CbGpPWpGaD
Budesonide—Fluocinonide—NR3C1—hematologic cancer	3.27e-05	0.0327	CrCbGaD
Budesonide—Beclomethasone—NR3C1—hematologic cancer	3.27e-05	0.0327	CrCbGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—hematologic cancer	3.27e-05	0.00237	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—STAT5A—hematologic cancer	3.27e-05	0.00237	CbGpPWpGaD
Budesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—hematologic cancer	3.26e-05	0.00236	CbGpPWpGaD
Budesonide—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—hematologic cancer	3.21e-05	0.00233	CbGpPWpGaD
Budesonide—Fluocinolone Acetonide—NR3C1—hematologic cancer	3.18e-05	0.0317	CrCbGaD
Budesonide—Alclometasone—NR3C1—hematologic cancer	3.18e-05	0.0317	CrCbGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—hematologic cancer	3.1e-05	0.00225	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—hematologic cancer	3.1e-05	0.00225	CbGpPWpGaD
Budesonide—Clobetasol propionate—NR3C1—hematologic cancer	3.1e-05	0.0309	CrCbGaD
Budesonide—Flunisolide—NR3C1—hematologic cancer	3.1e-05	0.0309	CrCbGaD
Budesonide—NR3C1—AP-1 transcription factor network—HLA-A—hematologic cancer	3.07e-05	0.00223	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—GATA3—hematologic cancer	3.07e-05	0.00222	CbGpPWpGaD
Budesonide—Paramethasone—NR3C1—hematologic cancer	3.06e-05	0.0305	CrCbGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—CSF2—hematologic cancer	3.04e-05	0.0022	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO1—hematologic cancer	3.02e-05	0.00219	CbGpPWpGaD
Budesonide—Ciclesonide—NR3C1—hematologic cancer	3.01e-05	0.03	CrCbGaD
Budesonide—NR3C1—Regulation of Androgen receptor activity—CREBBP—hematologic cancer	3e-05	0.00218	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—BAX—hematologic cancer	2.99e-05	0.00217	CbGpPWpGaD
Budesonide—NR3C1—Circadian Clock—CREB1—hematologic cancer	2.99e-05	0.00217	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—IL4—hematologic cancer	2.99e-05	0.00217	CbGpPWpGaD
Budesonide—Fluorometholone—NR3C1—hematologic cancer	2.98e-05	0.0298	CrCbGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL13—hematologic cancer	2.94e-05	0.00213	CbGpPWpGaD
Budesonide—NR3C1—Circadian Clock—CREBBP—hematologic cancer	2.91e-05	0.00211	CbGpPWpGaD
Budesonide—Methylprednisolone—NR3C1—hematologic cancer	2.89e-05	0.0288	CrCbGaD
Budesonide—NR3C1—AP-1 transcription factor network—ESR1—hematologic cancer	2.74e-05	0.00199	CbGpPWpGaD
Budesonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—hematologic cancer	2.72e-05	0.00198	CbGpPWpGaD
Budesonide—NR3C1—Endoderm Differentiation—NOTCH1—hematologic cancer	2.71e-05	0.00197	CbGpPWpGaD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—hematologic cancer	2.7e-05	0.00196	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—GATA3—hematologic cancer	2.65e-05	0.00192	CbGpPWpGaD
Budesonide—CYP3A4—Constitutive Androstane Receptor Pathway—HSP90AA1—hematologic cancer	2.65e-05	0.00192	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK2—hematologic cancer	2.59e-05	0.00188	CbGpPWpGaD
Budesonide—NR3C1—Regulation of Androgen receptor activity—MDM2—hematologic cancer	2.55e-05	0.00185	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—STAT1—hematologic cancer	2.51e-05	0.00182	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—FOS—hematologic cancer	2.47e-05	0.00179	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—CREB1—hematologic cancer	2.46e-05	0.00179	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK14—hematologic cancer	2.46e-05	0.00178	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—hematologic cancer	2.45e-05	0.00178	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—hematologic cancer	2.44e-05	0.00177	CbGpPWpGaD
Budesonide—Triamcinolone—NR3C1—hematologic cancer	2.43e-05	0.0243	CrCbGaD
Budesonide—NR3C1—AP-1 transcription factor network—CCL2—hematologic cancer	2.41e-05	0.00175	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—ZNF552—hematologic cancer	2.4e-05	0.00174	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—hematologic cancer	2.37e-05	0.00172	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—STAT5A—hematologic cancer	2.26e-05	0.00164	CbGpPWpGaD
Budesonide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—hematologic cancer	2.22e-05	0.00161	CbGpPWpGaD
Budesonide—NR3C1—Regulation of Androgen receptor activity—JUN—hematologic cancer	2.21e-05	0.00161	CbGpPWpGaD
Budesonide—Prednisone—NR3C1—hematologic cancer	2.21e-05	0.022	CrCbGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—hematologic cancer	2.2e-05	0.00159	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREB1—hematologic cancer	2.19e-05	0.00159	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—FOS—hematologic cancer	2.17e-05	0.00158	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—CREB1—hematologic cancer	2.17e-05	0.00158	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—hematologic cancer	2.14e-05	0.00155	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—NCOR1—hematologic cancer	2.12e-05	0.00154	CbGpPWpGaD
Budesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—hematologic cancer	2.12e-05	0.00154	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—hematologic cancer	2.11e-05	0.00153	CbGpPWpGaD
Budesonide—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—hematologic cancer	2.1e-05	0.00153	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—CDKN2A—hematologic cancer	2.1e-05	0.00153	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—AR—hematologic cancer	2.1e-05	0.00152	CbGpPWpGaD
Budesonide—NR3C1—Regulation of Androgen receptor activity—MAPK8—hematologic cancer	2.09e-05	0.00152	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—FOXO1—hematologic cancer	2.07e-05	0.0015	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—IFNG—hematologic cancer	2.05e-05	0.00149	CbGpPWpGaD
Budesonide—NR3C1—Regulation of Androgen receptor activity—EP300—hematologic cancer	2.04e-05	0.00148	CbGpPWpGaD
Budesonide—Prednisolone—NR3C1—hematologic cancer	2.03e-05	0.0203	CrCbGaD
Budesonide—Betamethasone—NR3C1—hematologic cancer	1.99e-05	0.0199	CrCbGaD
Budesonide—NR3C1—Generic Transcription Pathway—RARA—hematologic cancer	1.99e-05	0.00144	CbGpPWpGaD
Budesonide—NR3C1—Regulation of Androgen receptor activity—SRC—hematologic cancer	1.99e-05	0.00144	CbGpPWpGaD
Budesonide—NR3C1—Circadian Clock—EP300—hematologic cancer	1.98e-05	0.00144	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—FAS—hematologic cancer	1.9e-05	0.00138	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—CDKN1B—hematologic cancer	1.86e-05	0.00135	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—NR0B2—hematologic cancer	1.85e-05	0.00134	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—HES1—hematologic cancer	1.85e-05	0.00134	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL10—hematologic cancer	1.84e-05	0.00133	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—IL2—hematologic cancer	1.82e-05	0.00132	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—CASC3—hematologic cancer	1.82e-05	0.00132	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—IFNG—hematologic cancer	1.81e-05	0.00131	CbGpPWpGaD
Budesonide—Hydrocortisone—ABCG2—hematologic cancer	1.8e-05	0.018	CrCbGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—MDM2—hematologic cancer	1.8e-05	0.0013	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—CCND1—hematologic cancer	1.78e-05	0.00129	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—JUN—hematologic cancer	1.77e-05	0.00129	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—SLC35B2—hematologic cancer	1.77e-05	0.00128	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—EPHX1—hematologic cancer	1.74e-05	0.00126	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—PTEN—hematologic cancer	1.71e-05	0.00124	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—NCOR2—hematologic cancer	1.67e-05	0.00121	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—EP300—hematologic cancer	1.63e-05	0.00119	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—hematologic cancer	1.61e-05	0.00116	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—hematologic cancer	1.58e-05	0.00114	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—JUN—hematologic cancer	1.56e-05	0.00113	CbGpPWpGaD
Budesonide—Hydrocortisone—NR3C1—hematologic cancer	1.56e-05	0.0155	CrCbGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hematologic cancer	1.53e-05	0.00111	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—hematologic cancer	1.51e-05	0.0011	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—CREB1—hematologic cancer	1.5e-05	0.00109	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—hematologic cancer	1.48e-05	0.00107	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—RB1—hematologic cancer	1.46e-05	0.00106	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—hematologic cancer	1.45e-05	0.00106	CbGpPWpGaD
Budesonide—NR3C1—Endoderm Differentiation—TGFB1—hematologic cancer	1.45e-05	0.00106	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—EP300—hematologic cancer	1.44e-05	0.00105	CbGpPWpGaD
Budesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—hematologic cancer	1.43e-05	0.00104	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—MYC—hematologic cancer	1.42e-05	0.00103	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—TGFB1—hematologic cancer	1.42e-05	0.00103	CbGpPWpGaD
Budesonide—Methylprednisolone—ABCB1—hematologic cancer	1.39e-05	0.0139	CrCbGaD
Budesonide—Dexamethasone—ABCG2—hematologic cancer	1.34e-05	0.0134	CrCbGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—CREB1—hematologic cancer	1.3e-05	0.000942	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—hematologic cancer	1.29e-05	0.000936	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—hematologic cancer	1.27e-05	0.00092	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL6R—hematologic cancer	1.27e-05	0.000919	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—CREBBP—hematologic cancer	1.26e-05	0.000917	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—RARS—hematologic cancer	1.17e-05	0.000852	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—TP53—hematologic cancer	1.17e-05	0.000849	CbGpPWpGaD
Budesonide—Dexamethasone—NR3C1—hematologic cancer	1.16e-05	0.0116	CrCbGaD
Budesonide—CYP3A4—Biological oxidations—GSTO1—hematologic cancer	1.14e-05	0.000826	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—GSTO1—hematologic cancer	1.12e-05	0.000814	CbGpPWpGaD
Budesonide—Prednisone—ALB—hematologic cancer	1.12e-05	0.0111	CrCbGaD
Budesonide—NR3C1—Gene Expression—POLR3E—hematologic cancer	1.1e-05	0.000801	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—IL6—hematologic cancer	1.07e-05	0.000777	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—UGT1A1—hematologic cancer	1.07e-05	0.000776	CbGpPWpGaD
Budesonide—Prednisone—ABCB1—hematologic cancer	1.06e-05	0.0106	CrCbGaD
Budesonide—NR3C1—Generic Transcription Pathway—PARP1—hematologic cancer	1.06e-05	0.00077	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—UGT1A1—hematologic cancer	1.06e-05	0.000766	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—CDKN1A—hematologic cancer	1.05e-05	0.00076	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—hematologic cancer	1.03e-05	0.000748	CbGpPWpGaD
Budesonide—Prednisolone—ABCB1—hematologic cancer	9.81e-06	0.00979	CrCbGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL1B—hematologic cancer	9.63e-06	0.000699	CbGpPWpGaD
Budesonide—Betamethasone—ABCB1—hematologic cancer	9.62e-06	0.00959	CrCbGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—CASP3—hematologic cancer	9.61e-06	0.000697	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—RARA—hematologic cancer	9.57e-06	0.000694	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—TET2—hematologic cancer	9.57e-06	0.000694	CbGpPWpGaD
Budesonide—CYP3A4—Tryptophan metabolism—MDM2—hematologic cancer	9.44e-06	0.000685	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—hematologic cancer	9.44e-06	0.000685	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—RPLP1—hematologic cancer	9.38e-06	0.000681	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—STAT3—hematologic cancer	9.34e-06	0.000678	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—JUN—hematologic cancer	9.33e-06	0.000677	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—MTR—hematologic cancer	9.28e-06	0.000673	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—NR0B2—hematologic cancer	8.9e-06	0.000645	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—AR—hematologic cancer	8.88e-06	0.000644	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	8.83e-06	0.00064	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—hematologic cancer	8.79e-06	0.000638	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—hematologic cancer	8.7e-06	0.000632	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—TGFB1—hematologic cancer	8.66e-06	0.000628	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—EP300—hematologic cancer	8.61e-06	0.000625	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—DNMT3A—hematologic cancer	8.49e-06	0.000616	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—ELL—hematologic cancer	8.36e-06	0.000607	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—CDKN2B—hematologic cancer	8.18e-06	0.000593	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	8.16e-06	0.000592	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—TNF—hematologic cancer	8.09e-06	0.000587	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—NCOR2—hematologic cancer	8.03e-06	0.000583	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—NCOR1—hematologic cancer	7.76e-06	0.000563	CbGpPWpGaD
Budesonide—Hydrocortisone—ABCB1—hematologic cancer	7.51e-06	0.00749	CrCbGaD
Budesonide—NR3C1—Gene Expression—AGO2—hematologic cancer	7.4e-06	0.000537	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—DNMT3B—hematologic cancer	7.25e-06	0.000526	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—H3F3B—hematologic cancer	7.25e-06	0.000526	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—TNF—hematologic cancer	6.99e-06	0.000507	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—RPS14—hematologic cancer	6.63e-06	0.000481	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—NUP98—hematologic cancer	6.53e-06	0.000474	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—IL6—hematologic cancer	6.53e-06	0.000473	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—NUP214—hematologic cancer	6.29e-06	0.000457	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	6.12e-06	0.000444	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—ESR1—hematologic cancer	6.09e-06	0.000442	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	6.03e-06	0.000438	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—NOTCH1—hematologic cancer	5.89e-06	0.000427	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—HSPB1—hematologic cancer	5.8e-06	0.000421	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—EIF4EBP1—hematologic cancer	5.8e-06	0.000421	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL6—hematologic cancer	5.64e-06	0.000409	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	5.62e-06	0.000408	CbGpPWpGaD
Budesonide—Dexamethasone—ABCB1—hematologic cancer	5.59e-06	0.00558	CrCbGaD
Budesonide—NR3C1—Gene Expression—SMC1A—hematologic cancer	5.55e-06	0.000403	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	5.54e-06	0.000402	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—H3F3A—hematologic cancer	5.44e-06	0.000395	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—CREBBP—hematologic cancer	5.34e-06	0.000388	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—EZH2—hematologic cancer	5.22e-06	0.000379	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—PARP1—hematologic cancer	5.11e-06	0.000371	CbGpPWpGaD
Budesonide—Nausea—Gemcitabine—hematologic cancer	4.94e-06	8.33e-05	CcSEcCtD
Budesonide—Vomiting—Cisplatin—hematologic cancer	4.93e-06	8.31e-05	CcSEcCtD
Budesonide—NR3C1—Gene Expression—HDAC2—hematologic cancer	4.93e-06	0.000358	CbGpPWpGaD
Budesonide—Hyperhidrosis—Prednisone—hematologic cancer	4.92e-06	8.29e-05	CcSEcCtD
Budesonide—Vision blurred—Methotrexate—hematologic cancer	4.91e-06	8.28e-05	CcSEcCtD
Budesonide—Mental disorder—Epirubicin—hematologic cancer	4.91e-06	8.28e-05	CcSEcCtD
Budesonide—Rash—Cisplatin—hematologic cancer	4.89e-06	8.24e-05	CcSEcCtD
Budesonide—Dermatitis—Cisplatin—hematologic cancer	4.88e-06	8.23e-05	CcSEcCtD
Budesonide—Malnutrition—Epirubicin—hematologic cancer	4.88e-06	8.22e-05	CcSEcCtD
Budesonide—Diarrhoea—Etoposide—hematologic cancer	4.86e-06	8.19e-05	CcSEcCtD
Budesonide—Anorexia—Prednisone—hematologic cancer	4.85e-06	8.18e-05	CcSEcCtD
Budesonide—Eye disorder—Doxorubicin—hematologic cancer	4.85e-06	8.17e-05	CcSEcCtD
Budesonide—Ill-defined disorder—Methotrexate—hematologic cancer	4.84e-06	8.15e-05	CcSEcCtD
Budesonide—Anaemia—Methotrexate—hematologic cancer	4.82e-06	8.12e-05	CcSEcCtD
Budesonide—Feeling abnormal—Dexamethasone—hematologic cancer	4.82e-06	8.12e-05	CcSEcCtD
Budesonide—Feeling abnormal—Betamethasone—hematologic cancer	4.82e-06	8.12e-05	CcSEcCtD
Budesonide—Flushing—Doxorubicin—hematologic cancer	4.81e-06	8.11e-05	CcSEcCtD
Budesonide—Cardiac disorder—Doxorubicin—hematologic cancer	4.81e-06	8.11e-05	CcSEcCtD
Budesonide—Flatulence—Epirubicin—hematologic cancer	4.81e-06	8.1e-05	CcSEcCtD
Budesonide—Tension—Epirubicin—hematologic cancer	4.79e-06	8.07e-05	CcSEcCtD
Budesonide—Gastrointestinal pain—Dexamethasone—hematologic cancer	4.78e-06	8.06e-05	CcSEcCtD
Budesonide—Gastrointestinal pain—Betamethasone—hematologic cancer	4.78e-06	8.06e-05	CcSEcCtD
Budesonide—Dysgeusia—Epirubicin—hematologic cancer	4.78e-06	8.05e-05	CcSEcCtD
Budesonide—Hypersensitivity—Triamcinolone—hematologic cancer	4.75e-06	8e-05	CcSEcCtD
Budesonide—Nervousness—Epirubicin—hematologic cancer	4.74e-06	7.99e-05	CcSEcCtD
Budesonide—Back pain—Epirubicin—hematologic cancer	4.72e-06	7.95e-05	CcSEcCtD
Budesonide—Angiopathy—Doxorubicin—hematologic cancer	4.7e-06	7.93e-05	CcSEcCtD
Budesonide—Malaise—Methotrexate—hematologic cancer	4.7e-06	7.92e-05	CcSEcCtD
Budesonide—Dizziness—Etoposide—hematologic cancer	4.7e-06	7.92e-05	CcSEcCtD
Budesonide—Muscle spasms—Epirubicin—hematologic cancer	4.69e-06	7.91e-05	CcSEcCtD
Budesonide—CYP3A4—Metabolism—PHYH—hematologic cancer	4.69e-06	0.00034	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—FTCD—hematologic cancer	4.69e-06	0.00034	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GMPS—hematologic cancer	4.69e-06	0.00034	CbGpPWpGaD
Budesonide—Immune system disorder—Doxorubicin—hematologic cancer	4.68e-06	7.89e-05	CcSEcCtD
Budesonide—Vertigo—Methotrexate—hematologic cancer	4.68e-06	7.89e-05	CcSEcCtD
Budesonide—Mediastinal disorder—Doxorubicin—hematologic cancer	4.67e-06	7.88e-05	CcSEcCtD
Budesonide—Urticaria—Dexamethasone—hematologic cancer	4.64e-06	7.83e-05	CcSEcCtD
Budesonide—Urticaria—Betamethasone—hematologic cancer	4.64e-06	7.83e-05	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Prednisone—hematologic cancer	4.64e-06	7.82e-05	CcSEcCtD
Budesonide—Dizziness—Prednisolone—hematologic cancer	4.63e-06	7.81e-05	CcSEcCtD
Budesonide—Asthenia—Triamcinolone—hematologic cancer	4.62e-06	7.79e-05	CcSEcCtD
Budesonide—Abdominal pain—Betamethasone—hematologic cancer	4.62e-06	7.79e-05	CcSEcCtD
Budesonide—Abdominal pain—Dexamethasone—hematologic cancer	4.62e-06	7.79e-05	CcSEcCtD
Budesonide—Body temperature increased—Dexamethasone—hematologic cancer	4.62e-06	7.79e-05	CcSEcCtD
Budesonide—Body temperature increased—Betamethasone—hematologic cancer	4.62e-06	7.79e-05	CcSEcCtD
Budesonide—Nausea—Cisplatin—hematologic cancer	4.61e-06	7.76e-05	CcSEcCtD
Budesonide—Insomnia—Prednisone—hematologic cancer	4.6e-06	7.76e-05	CcSEcCtD
Budesonide—Vision blurred—Epirubicin—hematologic cancer	4.6e-06	7.75e-05	CcSEcCtD
Budesonide—Alopecia—Doxorubicin—hematologic cancer	4.58e-06	7.72e-05	CcSEcCtD
Budesonide—Paraesthesia—Prednisone—hematologic cancer	4.57e-06	7.7e-05	CcSEcCtD
Budesonide—Pruritus—Triamcinolone—hematologic cancer	4.56e-06	7.68e-05	CcSEcCtD
Budesonide—Cough—Methotrexate—hematologic cancer	4.55e-06	7.67e-05	CcSEcCtD
Budesonide—Mental disorder—Doxorubicin—hematologic cancer	4.54e-06	7.66e-05	CcSEcCtD
Budesonide—Ill-defined disorder—Epirubicin—hematologic cancer	4.53e-06	7.63e-05	CcSEcCtD
Budesonide—Vomiting—Etoposide—hematologic cancer	4.52e-06	7.61e-05	CcSEcCtD
Budesonide—Malnutrition—Doxorubicin—hematologic cancer	4.51e-06	7.61e-05	CcSEcCtD
Budesonide—Anaemia—Epirubicin—hematologic cancer	4.51e-06	7.6e-05	CcSEcCtD
Budesonide—Agitation—Epirubicin—hematologic cancer	4.48e-06	7.56e-05	CcSEcCtD
Budesonide—Dyspepsia—Prednisone—hematologic cancer	4.48e-06	7.55e-05	CcSEcCtD
Budesonide—Rash—Etoposide—hematologic cancer	4.48e-06	7.55e-05	CcSEcCtD
Budesonide—Dermatitis—Etoposide—hematologic cancer	4.47e-06	7.54e-05	CcSEcCtD
Budesonide—Headache—Etoposide—hematologic cancer	4.45e-06	7.5e-05	CcSEcCtD
Budesonide—Flatulence—Doxorubicin—hematologic cancer	4.45e-06	7.5e-05	CcSEcCtD
Budesonide—Myalgia—Methotrexate—hematologic cancer	4.44e-06	7.48e-05	CcSEcCtD
Budesonide—Arthralgia—Methotrexate—hematologic cancer	4.44e-06	7.48e-05	CcSEcCtD
Budesonide—Chest pain—Methotrexate—hematologic cancer	4.44e-06	7.48e-05	CcSEcCtD
Budesonide—Tension—Doxorubicin—hematologic cancer	4.43e-06	7.47e-05	CcSEcCtD
Budesonide—Decreased appetite—Prednisone—hematologic cancer	4.43e-06	7.46e-05	CcSEcCtD
Budesonide—Dysgeusia—Doxorubicin—hematologic cancer	4.42e-06	7.45e-05	CcSEcCtD
Budesonide—Rash—Prednisolone—hematologic cancer	4.42e-06	7.45e-05	CcSEcCtD
Budesonide—Dermatitis—Prednisolone—hematologic cancer	4.41e-06	7.44e-05	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	4.41e-06	7.43e-05	CcSEcCtD
Budesonide—Malaise—Epirubicin—hematologic cancer	4.4e-06	7.42e-05	CcSEcCtD
Budesonide—Fatigue—Prednisone—hematologic cancer	4.39e-06	7.4e-05	CcSEcCtD
Budesonide—Headache—Prednisolone—hematologic cancer	4.39e-06	7.4e-05	CcSEcCtD
Budesonide—Discomfort—Methotrexate—hematologic cancer	4.39e-06	7.39e-05	CcSEcCtD
Budesonide—Nervousness—Doxorubicin—hematologic cancer	4.38e-06	7.39e-05	CcSEcCtD
Budesonide—Vertigo—Epirubicin—hematologic cancer	4.38e-06	7.39e-05	CcSEcCtD
Budesonide—Syncope—Epirubicin—hematologic cancer	4.38e-06	7.37e-05	CcSEcCtD
Budesonide—Back pain—Doxorubicin—hematologic cancer	4.37e-06	7.36e-05	CcSEcCtD
Budesonide—Constipation—Prednisone—hematologic cancer	4.35e-06	7.34e-05	CcSEcCtD
Budesonide—Muscle spasms—Doxorubicin—hematologic cancer	4.34e-06	7.31e-05	CcSEcCtD
Budesonide—Palpitations—Epirubicin—hematologic cancer	4.31e-06	7.27e-05	CcSEcCtD
Budesonide—Confusional state—Methotrexate—hematologic cancer	4.29e-06	7.23e-05	CcSEcCtD
Budesonide—Loss of consciousness—Epirubicin—hematologic cancer	4.29e-06	7.23e-05	CcSEcCtD
Budesonide—CYP3A4—Metabolism—SMPD3—hematologic cancer	4.29e-06	0.000311	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—AR—hematologic cancer	4.27e-06	0.00031	CbGpPWpGaD
Budesonide—Dizziness—Triamcinolone—hematologic cancer	4.26e-06	7.18e-05	CcSEcCtD
Budesonide—Cough—Epirubicin—hematologic cancer	4.26e-06	7.18e-05	CcSEcCtD
Budesonide—Anaphylactic shock—Methotrexate—hematologic cancer	4.25e-06	7.17e-05	CcSEcCtD
Budesonide—Vision blurred—Doxorubicin—hematologic cancer	4.25e-06	7.17e-05	CcSEcCtD
Budesonide—Infection—Methotrexate—hematologic cancer	4.23e-06	7.12e-05	CcSEcCtD
Budesonide—Nausea—Etoposide—hematologic cancer	4.22e-06	7.11e-05	CcSEcCtD
Budesonide—Hypertension—Epirubicin—hematologic cancer	4.21e-06	7.1e-05	CcSEcCtD
Budesonide—Feeling abnormal—Prednisone—hematologic cancer	4.2e-06	7.07e-05	CcSEcCtD
Budesonide—Asthenia—Dexamethasone—hematologic cancer	4.19e-06	7.07e-05	CcSEcCtD
Budesonide—Asthenia—Betamethasone—hematologic cancer	4.19e-06	7.07e-05	CcSEcCtD
Budesonide—Ill-defined disorder—Doxorubicin—hematologic cancer	4.19e-06	7.06e-05	CcSEcCtD
Budesonide—Nervous system disorder—Methotrexate—hematologic cancer	4.17e-06	7.03e-05	CcSEcCtD
Budesonide—Anaemia—Doxorubicin—hematologic cancer	4.17e-06	7.03e-05	CcSEcCtD
Budesonide—Gastrointestinal pain—Prednisone—hematologic cancer	4.16e-06	7.02e-05	CcSEcCtD
Budesonide—Nausea—Prednisolone—hematologic cancer	4.16e-06	7.01e-05	CcSEcCtD
Budesonide—Arthralgia—Epirubicin—hematologic cancer	4.15e-06	7e-05	CcSEcCtD
Budesonide—Chest pain—Epirubicin—hematologic cancer	4.15e-06	7e-05	CcSEcCtD
Budesonide—Myalgia—Epirubicin—hematologic cancer	4.15e-06	7e-05	CcSEcCtD
Budesonide—Agitation—Doxorubicin—hematologic cancer	4.15e-06	6.99e-05	CcSEcCtD
Budesonide—Anxiety—Epirubicin—hematologic cancer	4.14e-06	6.98e-05	CcSEcCtD
Budesonide—Pruritus—Betamethasone—hematologic cancer	4.14e-06	6.97e-05	CcSEcCtD
Budesonide—Pruritus—Dexamethasone—hematologic cancer	4.14e-06	6.97e-05	CcSEcCtD
Budesonide—Skin disorder—Methotrexate—hematologic cancer	4.13e-06	6.97e-05	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	4.13e-06	6.95e-05	CcSEcCtD
Budesonide—Hyperhidrosis—Methotrexate—hematologic cancer	4.11e-06	6.93e-05	CcSEcCtD
Budesonide—Discomfort—Epirubicin—hematologic cancer	4.1e-06	6.92e-05	CcSEcCtD
Budesonide—Vomiting—Triamcinolone—hematologic cancer	4.1e-06	6.9e-05	CcSEcCtD
Budesonide—Malaise—Doxorubicin—hematologic cancer	4.07e-06	6.86e-05	CcSEcCtD
Budesonide—Rash—Triamcinolone—hematologic cancer	4.06e-06	6.85e-05	CcSEcCtD
Budesonide—Dry mouth—Epirubicin—hematologic cancer	4.06e-06	6.85e-05	CcSEcCtD
Budesonide—Dermatitis—Triamcinolone—hematologic cancer	4.06e-06	6.84e-05	CcSEcCtD
Budesonide—Vertigo—Doxorubicin—hematologic cancer	4.06e-06	6.84e-05	CcSEcCtD
Budesonide—Anorexia—Methotrexate—hematologic cancer	4.06e-06	6.84e-05	CcSEcCtD
Budesonide—Syncope—Doxorubicin—hematologic cancer	4.05e-06	6.82e-05	CcSEcCtD
Budesonide—Urticaria—Prednisone—hematologic cancer	4.04e-06	6.82e-05	CcSEcCtD
Budesonide—Headache—Triamcinolone—hematologic cancer	4.04e-06	6.8e-05	CcSEcCtD
Budesonide—Body temperature increased—Prednisone—hematologic cancer	4.02e-06	6.78e-05	CcSEcCtD
Budesonide—Abdominal pain—Prednisone—hematologic cancer	4.02e-06	6.78e-05	CcSEcCtD
Budesonide—Confusional state—Epirubicin—hematologic cancer	4.01e-06	6.77e-05	CcSEcCtD
Budesonide—Diarrhoea—Betamethasone—hematologic cancer	4e-06	6.74e-05	CcSEcCtD
Budesonide—Diarrhoea—Dexamethasone—hematologic cancer	4e-06	6.74e-05	CcSEcCtD
Budesonide—Palpitations—Doxorubicin—hematologic cancer	3.99e-06	6.72e-05	CcSEcCtD
Budesonide—Anaphylactic shock—Epirubicin—hematologic cancer	3.98e-06	6.71e-05	CcSEcCtD
Budesonide—Loss of consciousness—Doxorubicin—hematologic cancer	3.97e-06	6.69e-05	CcSEcCtD
Budesonide—Infection—Epirubicin—hematologic cancer	3.96e-06	6.67e-05	CcSEcCtD
Budesonide—Cough—Doxorubicin—hematologic cancer	3.94e-06	6.64e-05	CcSEcCtD
Budesonide—NR3C1—Gene Expression—CDKN2B—hematologic cancer	3.94e-06	0.000286	CbGpPWpGaD
Budesonide—Shock—Epirubicin—hematologic cancer	3.92e-06	6.6e-05	CcSEcCtD
Budesonide—Nervous system disorder—Epirubicin—hematologic cancer	3.9e-06	6.58e-05	CcSEcCtD
Budesonide—Hypertension—Doxorubicin—hematologic cancer	3.9e-06	6.57e-05	CcSEcCtD
Budesonide—Tachycardia—Epirubicin—hematologic cancer	3.89e-06	6.55e-05	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Methotrexate—hematologic cancer	3.88e-06	6.53e-05	CcSEcCtD
Budesonide—Skin disorder—Epirubicin—hematologic cancer	3.87e-06	6.52e-05	CcSEcCtD
Budesonide—Dizziness—Betamethasone—hematologic cancer	3.87e-06	6.52e-05	CcSEcCtD
Budesonide—Dizziness—Dexamethasone—hematologic cancer	3.87e-06	6.52e-05	CcSEcCtD
Budesonide—Hyperhidrosis—Epirubicin—hematologic cancer	3.85e-06	6.49e-05	CcSEcCtD
Budesonide—Insomnia—Methotrexate—hematologic cancer	3.85e-06	6.49e-05	CcSEcCtD
Budesonide—Myalgia—Doxorubicin—hematologic cancer	3.84e-06	6.48e-05	CcSEcCtD
Budesonide—Chest pain—Doxorubicin—hematologic cancer	3.84e-06	6.48e-05	CcSEcCtD
Budesonide—Arthralgia—Doxorubicin—hematologic cancer	3.84e-06	6.48e-05	CcSEcCtD
Budesonide—Anxiety—Doxorubicin—hematologic cancer	3.83e-06	6.45e-05	CcSEcCtD
Budesonide—Nausea—Triamcinolone—hematologic cancer	3.83e-06	6.45e-05	CcSEcCtD
Budesonide—Paraesthesia—Methotrexate—hematologic cancer	3.82e-06	6.44e-05	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	3.82e-06	6.43e-05	CcSEcCtD
Budesonide—Discomfort—Doxorubicin—hematologic cancer	3.8e-06	6.4e-05	CcSEcCtD
Budesonide—Anorexia—Epirubicin—hematologic cancer	3.8e-06	6.4e-05	CcSEcCtD
Budesonide—Dyspnoea—Methotrexate—hematologic cancer	3.79e-06	6.39e-05	CcSEcCtD
Budesonide—Somnolence—Methotrexate—hematologic cancer	3.78e-06	6.37e-05	CcSEcCtD
Budesonide—Dry mouth—Doxorubicin—hematologic cancer	3.76e-06	6.33e-05	CcSEcCtD
Budesonide—Hypersensitivity—Prednisone—hematologic cancer	3.75e-06	6.32e-05	CcSEcCtD
Budesonide—CYP3A4—Metabolism—ASNS—hematologic cancer	3.75e-06	0.000272	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—DCK—hematologic cancer	3.75e-06	0.000272	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—B3GAT1—hematologic cancer	3.75e-06	0.000272	CbGpPWpGaD
Budesonide—Dyspepsia—Methotrexate—hematologic cancer	3.75e-06	6.31e-05	CcSEcCtD
Budesonide—NR3C1—Gene Expression—NCOR1—hematologic cancer	3.74e-06	0.000271	CbGpPWpGaD
Budesonide—Vomiting—Dexamethasone—hematologic cancer	3.72e-06	6.26e-05	CcSEcCtD
Budesonide—Vomiting—Betamethasone—hematologic cancer	3.72e-06	6.26e-05	CcSEcCtD
Budesonide—Confusional state—Doxorubicin—hematologic cancer	3.71e-06	6.26e-05	CcSEcCtD
Budesonide—Decreased appetite—Methotrexate—hematologic cancer	3.7e-06	6.23e-05	CcSEcCtD
Budesonide—Rash—Betamethasone—hematologic cancer	3.69e-06	6.21e-05	CcSEcCtD
Budesonide—Rash—Dexamethasone—hematologic cancer	3.69e-06	6.21e-05	CcSEcCtD
Budesonide—Anaphylactic shock—Doxorubicin—hematologic cancer	3.68e-06	6.21e-05	CcSEcCtD
Budesonide—Dermatitis—Betamethasone—hematologic cancer	3.68e-06	6.21e-05	CcSEcCtD
Budesonide—Dermatitis—Dexamethasone—hematologic cancer	3.68e-06	6.21e-05	CcSEcCtD
Budesonide—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.67e-06	6.19e-05	CcSEcCtD
Budesonide—Fatigue—Methotrexate—hematologic cancer	3.67e-06	6.18e-05	CcSEcCtD
Budesonide—Headache—Betamethasone—hematologic cancer	3.66e-06	6.17e-05	CcSEcCtD
Budesonide—Headache—Dexamethasone—hematologic cancer	3.66e-06	6.17e-05	CcSEcCtD
Budesonide—Infection—Doxorubicin—hematologic cancer	3.66e-06	6.17e-05	CcSEcCtD
Budesonide—Asthenia—Prednisone—hematologic cancer	3.65e-06	6.16e-05	CcSEcCtD
Budesonide—Pain—Methotrexate—hematologic cancer	3.64e-06	6.13e-05	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Epirubicin—hematologic cancer	3.63e-06	6.11e-05	CcSEcCtD
Budesonide—Shock—Doxorubicin—hematologic cancer	3.62e-06	6.11e-05	CcSEcCtD
Budesonide—Nervous system disorder—Doxorubicin—hematologic cancer	3.61e-06	6.09e-05	CcSEcCtD
Budesonide—Pruritus—Prednisone—hematologic cancer	3.6e-06	6.07e-05	CcSEcCtD
Budesonide—Insomnia—Epirubicin—hematologic cancer	3.6e-06	6.07e-05	CcSEcCtD
Budesonide—Tachycardia—Doxorubicin—hematologic cancer	3.6e-06	6.06e-05	CcSEcCtD
Budesonide—Skin disorder—Doxorubicin—hematologic cancer	3.58e-06	6.03e-05	CcSEcCtD
Budesonide—Paraesthesia—Epirubicin—hematologic cancer	3.58e-06	6.03e-05	CcSEcCtD
Budesonide—Hyperhidrosis—Doxorubicin—hematologic cancer	3.56e-06	6e-05	CcSEcCtD
Budesonide—CYP3A4—Metabolism—HDC—hematologic cancer	3.55e-06	0.000258	CbGpPWpGaD
Budesonide—Dyspnoea—Epirubicin—hematologic cancer	3.55e-06	5.98e-05	CcSEcCtD
Budesonide—Somnolence—Epirubicin—hematologic cancer	3.54e-06	5.97e-05	CcSEcCtD
Budesonide—Anorexia—Doxorubicin—hematologic cancer	3.51e-06	5.92e-05	CcSEcCtD
Budesonide—Feeling abnormal—Methotrexate—hematologic cancer	3.51e-06	5.91e-05	CcSEcCtD
Budesonide—Dyspepsia—Epirubicin—hematologic cancer	3.51e-06	5.91e-05	CcSEcCtD
Budesonide—Diarrhoea—Prednisone—hematologic cancer	3.48e-06	5.87e-05	CcSEcCtD
Budesonide—Gastrointestinal pain—Methotrexate—hematologic cancer	3.48e-06	5.86e-05	CcSEcCtD
Budesonide—Nausea—Betamethasone—hematologic cancer	3.47e-06	5.85e-05	CcSEcCtD
Budesonide—Nausea—Dexamethasone—hematologic cancer	3.47e-06	5.85e-05	CcSEcCtD
Budesonide—Decreased appetite—Epirubicin—hematologic cancer	3.46e-06	5.83e-05	CcSEcCtD
Budesonide—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.44e-06	5.79e-05	CcSEcCtD
Budesonide—Fatigue—Epirubicin—hematologic cancer	3.43e-06	5.79e-05	CcSEcCtD
Budesonide—Pain—Epirubicin—hematologic cancer	3.41e-06	5.74e-05	CcSEcCtD
Budesonide—Constipation—Epirubicin—hematologic cancer	3.41e-06	5.74e-05	CcSEcCtD
Budesonide—Urticaria—Methotrexate—hematologic cancer	3.38e-06	5.7e-05	CcSEcCtD
Budesonide—Dizziness—Prednisone—hematologic cancer	3.37e-06	5.67e-05	CcSEcCtD
Budesonide—Abdominal pain—Methotrexate—hematologic cancer	3.36e-06	5.67e-05	CcSEcCtD
Budesonide—Body temperature increased—Methotrexate—hematologic cancer	3.36e-06	5.67e-05	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	3.36e-06	5.66e-05	CcSEcCtD
Budesonide—Insomnia—Doxorubicin—hematologic cancer	3.33e-06	5.62e-05	CcSEcCtD
Budesonide—Paraesthesia—Doxorubicin—hematologic cancer	3.31e-06	5.58e-05	CcSEcCtD
Budesonide—Dyspnoea—Doxorubicin—hematologic cancer	3.28e-06	5.54e-05	CcSEcCtD
Budesonide—Feeling abnormal—Epirubicin—hematologic cancer	3.28e-06	5.53e-05	CcSEcCtD
Budesonide—Somnolence—Doxorubicin—hematologic cancer	3.28e-06	5.52e-05	CcSEcCtD
Budesonide—Gastrointestinal pain—Epirubicin—hematologic cancer	3.26e-06	5.49e-05	CcSEcCtD
Budesonide—CYP3A4—Metabolism—CDA—hematologic cancer	3.25e-06	0.000236	CbGpPWpGaD
Budesonide—Dyspepsia—Doxorubicin—hematologic cancer	3.24e-06	5.47e-05	CcSEcCtD
Budesonide—Vomiting—Prednisone—hematologic cancer	3.24e-06	5.46e-05	CcSEcCtD
Budesonide—Rash—Prednisone—hematologic cancer	3.21e-06	5.41e-05	CcSEcCtD
Budesonide—Dermatitis—Prednisone—hematologic cancer	3.21e-06	5.41e-05	CcSEcCtD
Budesonide—Decreased appetite—Doxorubicin—hematologic cancer	3.2e-06	5.4e-05	CcSEcCtD
Budesonide—Headache—Prednisone—hematologic cancer	3.19e-06	5.38e-05	CcSEcCtD
Budesonide—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.18e-06	5.36e-05	CcSEcCtD
Budesonide—Fatigue—Doxorubicin—hematologic cancer	3.18e-06	5.35e-05	CcSEcCtD
Budesonide—NR3C1—Generic Transcription Pathway—MYC—hematologic cancer	3.17e-06	0.00023	CbGpPWpGaD
Budesonide—Urticaria—Epirubicin—hematologic cancer	3.16e-06	5.33e-05	CcSEcCtD
Budesonide—Constipation—Doxorubicin—hematologic cancer	3.15e-06	5.31e-05	CcSEcCtD
Budesonide—Pain—Doxorubicin—hematologic cancer	3.15e-06	5.31e-05	CcSEcCtD
Budesonide—Body temperature increased—Epirubicin—hematologic cancer	3.15e-06	5.3e-05	CcSEcCtD
Budesonide—Abdominal pain—Epirubicin—hematologic cancer	3.15e-06	5.3e-05	CcSEcCtD
Budesonide—Hypersensitivity—Methotrexate—hematologic cancer	3.13e-06	5.28e-05	CcSEcCtD
Budesonide—CYP3A4—Metabolism—PC—hematologic cancer	3.13e-06	0.000227	CbGpPWpGaD
Budesonide—Asthenia—Methotrexate—hematologic cancer	3.05e-06	5.14e-05	CcSEcCtD
Budesonide—Feeling abnormal—Doxorubicin—hematologic cancer	3.04e-06	5.12e-05	CcSEcCtD
Budesonide—Nausea—Prednisone—hematologic cancer	3.02e-06	5.1e-05	CcSEcCtD
Budesonide—CYP3A4—Metabolism—GBA—hematologic cancer	3.02e-06	0.000219	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SLC35B2—hematologic cancer	3.02e-06	0.000219	CbGpPWpGaD
Budesonide—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.01e-06	5.08e-05	CcSEcCtD
Budesonide—Pruritus—Methotrexate—hematologic cancer	3.01e-06	5.07e-05	CcSEcCtD
Budesonide—NR3C1—Gene Expression—MAPK14—hematologic cancer	2.99e-06	0.000217	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—ESR1—hematologic cancer	2.93e-06	0.000213	CbGpPWpGaD
Budesonide—Hypersensitivity—Epirubicin—hematologic cancer	2.93e-06	4.94e-05	CcSEcCtD
Budesonide—Urticaria—Doxorubicin—hematologic cancer	2.93e-06	4.93e-05	CcSEcCtD
Budesonide—Abdominal pain—Doxorubicin—hematologic cancer	2.91e-06	4.91e-05	CcSEcCtD
Budesonide—Body temperature increased—Doxorubicin—hematologic cancer	2.91e-06	4.91e-05	CcSEcCtD
Budesonide—Diarrhoea—Methotrexate—hematologic cancer	2.91e-06	4.91e-05	CcSEcCtD
Budesonide—Asthenia—Epirubicin—hematologic cancer	2.86e-06	4.81e-05	CcSEcCtD
Budesonide—NR3C1—Gene Expression—NOTCH1—hematologic cancer	2.84e-06	0.000206	CbGpPWpGaD
Budesonide—Pruritus—Epirubicin—hematologic cancer	2.82e-06	4.75e-05	CcSEcCtD
Budesonide—Dizziness—Methotrexate—hematologic cancer	2.81e-06	4.74e-05	CcSEcCtD
Budesonide—CYP3A4—Metabolism—MTAP—hematologic cancer	2.76e-06	0.0002	CbGpPWpGaD
Budesonide—Diarrhoea—Epirubicin—hematologic cancer	2.72e-06	4.59e-05	CcSEcCtD
Budesonide—Hypersensitivity—Doxorubicin—hematologic cancer	2.71e-06	4.57e-05	CcSEcCtD
Budesonide—Vomiting—Methotrexate—hematologic cancer	2.71e-06	4.56e-05	CcSEcCtD
Budesonide—Rash—Methotrexate—hematologic cancer	2.68e-06	4.52e-05	CcSEcCtD
Budesonide—Dermatitis—Methotrexate—hematologic cancer	2.68e-06	4.52e-05	CcSEcCtD
Budesonide—Headache—Methotrexate—hematologic cancer	2.67e-06	4.49e-05	CcSEcCtD
Budesonide—Asthenia—Doxorubicin—hematologic cancer	2.64e-06	4.46e-05	CcSEcCtD
Budesonide—Dizziness—Epirubicin—hematologic cancer	2.63e-06	4.44e-05	CcSEcCtD
Budesonide—Pruritus—Doxorubicin—hematologic cancer	2.61e-06	4.39e-05	CcSEcCtD
Budesonide—NR3C1—Gene Expression—CREBBP—hematologic cancer	2.57e-06	0.000187	CbGpPWpGaD
Budesonide—Vomiting—Epirubicin—hematologic cancer	2.53e-06	4.27e-05	CcSEcCtD
Budesonide—Nausea—Methotrexate—hematologic cancer	2.53e-06	4.26e-05	CcSEcCtD
Budesonide—Diarrhoea—Doxorubicin—hematologic cancer	2.52e-06	4.25e-05	CcSEcCtD
Budesonide—Rash—Epirubicin—hematologic cancer	2.51e-06	4.23e-05	CcSEcCtD
Budesonide—Dermatitis—Epirubicin—hematologic cancer	2.51e-06	4.23e-05	CcSEcCtD
Budesonide—Headache—Epirubicin—hematologic cancer	2.49e-06	4.2e-05	CcSEcCtD
Budesonide—CYP3A4—Metabolism—FHL2—hematologic cancer	2.46e-06	0.000179	CbGpPWpGaD
Budesonide—Dizziness—Doxorubicin—hematologic cancer	2.44e-06	4.11e-05	CcSEcCtD
Budesonide—CYP3A4—Metabolism—AGRN—hematologic cancer	2.41e-06	0.000175	CbGpPWpGaD
Budesonide—Nausea—Epirubicin—hematologic cancer	2.37e-06	3.99e-05	CcSEcCtD
Budesonide—Vomiting—Doxorubicin—hematologic cancer	2.34e-06	3.95e-05	CcSEcCtD
Budesonide—Rash—Doxorubicin—hematologic cancer	2.32e-06	3.92e-05	CcSEcCtD
Budesonide—Dermatitis—Doxorubicin—hematologic cancer	2.32e-06	3.91e-05	CcSEcCtD
Budesonide—Headache—Doxorubicin—hematologic cancer	2.31e-06	3.89e-05	CcSEcCtD
Budesonide—CYP3A4—Metabolism—IDH2—hematologic cancer	2.29e-06	0.000166	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HMMR—hematologic cancer	2.29e-06	0.000166	CbGpPWpGaD
Budesonide—Nausea—Doxorubicin—hematologic cancer	2.19e-06	3.69e-05	CcSEcCtD
Budesonide—CYP3A4—Metabolism—ARNTL—hematologic cancer	2.15e-06	0.000156	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CA9—hematologic cancer	2.09e-06	0.000152	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ACP5—hematologic cancer	2.09e-06	0.000152	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NCOR2—hematologic cancer	2.07e-06	0.00015	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—IDH1—hematologic cancer	1.97e-06	0.000143	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ABCC3—hematologic cancer	1.95e-06	0.000141	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTO1—hematologic cancer	1.95e-06	0.000141	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—TXN—hematologic cancer	1.95e-06	0.000141	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SPHK1—hematologic cancer	1.9e-06	0.000138	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—UGT1A1—hematologic cancer	1.83e-06	0.000133	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SLC22A1—hematologic cancer	1.78e-06	0.000129	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CRABP1—hematologic cancer	1.78e-06	0.000129	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ALOX5—hematologic cancer	1.73e-06	0.000126	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NUP98—hematologic cancer	1.68e-06	0.000122	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ADCY7—hematologic cancer	1.63e-06	0.000118	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NCOA3—hematologic cancer	1.63e-06	0.000118	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NUP214—hematologic cancer	1.62e-06	0.000118	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ABCG2—hematologic cancer	1.59e-06	0.000115	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—MTR—hematologic cancer	1.59e-06	0.000115	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—MAPK3—hematologic cancer	1.57e-06	0.000114	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ENO2—hematologic cancer	1.56e-06	0.000113	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—MYC—hematologic cancer	1.53e-06	0.000111	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTT1—hematologic cancer	1.51e-06	0.00011	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SDC1—hematologic cancer	1.48e-06	0.000107	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NQO1—hematologic cancer	1.25e-06	9.1e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CD44—hematologic cancer	1.25e-06	9.1e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYCS—hematologic cancer	1.19e-06	8.61e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.18e-06	8.56e-05	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—AKT1—hematologic cancer	1.06e-06	7.68e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.05e-06	7.59e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ABCB1—hematologic cancer	9.9e-07	7.18e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NCOR1—hematologic cancer	9.61e-07	6.97e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTM1—hematologic cancer	9.61e-07	6.97e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—MTHFR—hematologic cancer	8.5e-07	6.16e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PIK3CG—hematologic cancer	7.14e-07	5.18e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CREBBP—hematologic cancer	6.62e-07	4.8e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PIK3CD—hematologic cancer	6.28e-07	4.55e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ALB—hematologic cancer	6.2e-07	4.49e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PIK3R1—hematologic cancer	5.93e-07	4.3e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PIK3CB—hematologic cancer	5.47e-07	3.97e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PTEN—hematologic cancer	4.73e-07	3.43e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—EP300—hematologic cancer	4.51e-07	3.27e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PIK3CA—hematologic cancer	3.33e-07	2.42e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—AKT1—hematologic cancer	2.72e-07	1.98e-05	CbGpPWpGaD
